TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International Inc. has announced that its Board of Directors will meet on March 6, 2025, to approve and publish the annual financial results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment. A conference call is scheduled on the same day to discuss the financial results, which suggests an effort to maintain transparent communication with its stakeholders and could impact investor confidence and stock market positioning.
More about JD Health International, Inc.
JD Health International Inc. is a company incorporated in the Cayman Islands with limited liability, focusing on health-related services and products. It operates within the healthcare industry, providing a range of health management solutions and pharmaceutical products, primarily in the Chinese market.
YTD Price Performance: 25.44%
Average Trading Volume: 11,680,196
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$114.3B
For detailed information about 6618 stock, go to TipRanks’ Stock Analysis page.